ACP1 genetic polymorphism and coronary artery disease: An association study

Cardiology

Volumn 113, Issue 4, 2009, Pages 236-242

  Banci, M ^a   Saccucci, P ^b   D'Annibale, F ^b   Dofcaci, A ^a   Trionfera, G ^a   Magrini, A ^b   Bottini, N ^b   Bottini, E ^b   Gloria Bottini, F ^b  

^a Valmontone Hospital   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

ACP1 polymorphism; Atherosclerosis; Coronary artery disease

Indexed keywords

ACID PHOSPHATASE; CHOLESTEROL; GENOMIC DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD SAMPLING; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE ASSOCIATION; DNA DETERMINATION; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; ITALY; MAJOR CLINICAL STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS; RISK FACTORS; ROME; SEX DISTRIBUTION;

EID: 60749089388     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000203405     Document Type: Article

References (27)

1. Hansson GK: Inflammation and immune response in atherosclerosis. Curr Atheroscler Resp 1999; 1: 150 -155.
2. Ostos MA, Recalde D, Zakin MM, Scott-Al-gara D: Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett 2002; 519 : 23-29.
3. Frostegard J: Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25:1776 -1785.
4. Pertovaara M, Raitalia A, Juonala M, Kä-hönen M, Lehtimäki T, Viikari JS, Raitaka ri OT, Hurme M: Autoimmunity and atherosclerosis: functional polymorphism of PTPN22 is associated with phenotypes related to the risk of atherosclerosis: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 2007; 147 : 265-269.
5. Gloria-Bottini F, Bottini N, Renzetti G, Bottini E: ACP1 and Th class of immunological disease: evidence of interaction with gender. Int Arch Allerg y Immunol 2007; 143 : 170 -176.
6. Bottini N, Stefanini L, Williams S, Alonso A, Jascur T, Abraham RT, Couture C, Mustelin T: Activation of ZAP-70 through specific de-phosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002; 277: 24220-24224.
7. Spencer N, Hopkinson DA, Harris H: Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 1964; 201: 299-300.
8. Bott i n i E , Gloria-Bot t i ni F, Borg iani P: ACP1 and human adaptability. 1. Association with common diseases: a case-control study. Hum Genet 1995; 96:629-637.
9. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T: Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 2002; 50:95-104.
10. Sensabaugh GF, Lazaruk KA: A Taq1 site identifies the * A allele at the ACP1 locus. Hum Mol Genet 1993; 2: 1079.
11. Dissing J: Immunochemical characterization of human red cell acid phosphatase isozymes. Biochem Genet 1987; 25: 901-918.
12. Chiarugi P, Cirri P, Marra F, Raugei G, Camici G, Manao G, Ramponi G: LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. Biochem Biophys Res Commun 1997; 238: 676 - 682 .
13. Shekels LL, Smith AJ, Van Etten RL, Bernlohr DA: Identification of the adipocyte acid phosphatase as a PAO-sensitive t y rosyl phosphatase. Protein Sci 1992; 1: 710 -721.
14. Buelt MK, Xu Z, Banaszak LJ, Bernlohr DA: Structural and functional characterization of the phosphorylated adipocyte lipid-binding protein (pp15). Biochemistry 1992; 31: 3493-3499.
15. Elchebly M, Cheng A, Tremblay ML: Modulation of insulin signaling by protein tyrosine phosphatases. J Mol Med 2000; 78: 473-482.
16. Liao K, Hoffman RD, Lane MD: Phosphoty-rosyl turnover in insulin signaling: characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J Biol Chem 1991; 266: 6544-6553.
17. Stefani M, Caselli A, Bucciantini M, Pazzagli L, Dolfi F, Camici G, Manao G, Ramponi G: Dephosphorylation of tyrosine phosphory-lated synthetic peptides by rat liver phospho-tyrosine protein phosphatase isoenzymes. FEBS Lett 1993; 326: 131-134.
18. Lazaruk KD: Molecular genetics of human red cell acid phosphatase; PhD dissertation, University of California, Berkeley, 1995.
19. Kunkel LM, Smith KD, Boyer SH, Borga-onkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM: Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74:1245-1249.
20. Sokal RR, Rohlf FJ: Biometry. New York, Freeman, 1981, pp 253-261.
21. Statistical Package for the Social Sciences: SPSS/PC+ Version 5.0. Chicago, SPSS, 1992.
22. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 1999; 283:1277-1278.
23. Gloria-Bottini F, Gerlini G, Lucarini N, Borgiani P, A mante A, La Torre M, Antonacci E, Bottini E: Phosphotyrosine protein phos-phatases and diabetic pregnancy: association between low molecular weight acid phosphatase and degree of glycemic control. Experientia 1996; 52:340-343.
24. Harrison ML, Rathinavelu P, Arese P, Geahlen RL, Low PS: Role of band 3 tyrosine phosphorylation in the regulation of eryth-rocyte glycolysis. J Biol Chem 1991; 266: 4106 -4111.
25. Pandey SK, Yu XX, Watts LM, Michael MD, Sloop KW, Rivard AR, Leedom TA, Man-chem VP, Samadzadeh L, McKay RA, Monia BP, Bhanot S: Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. J Biol Chem 2007; 282: 14291-14299.
26. Seki N, Hashimoto N, Taira M, Yagi S, Yo-shida Y, Ishikawa K, Suzuki Y, Sano H, Horiuchi S, Yoshida S, Sakurai K, Yagui K, Makino H, Saito Y: Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes. Metabolism 2007; 56: 1591-1598.
27. Campbell M, Anderson P, Trimble ER: Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A. Diabetologia 2008;51:1068-1080.